Table 2.
Hemoglobin electrophoresis results
| Results of hemoglobin electrophoresis | HbA | HbA2 | HbAN1 | HbC | HbF | HbS |
|---|---|---|---|---|---|---|
| Minor β- thalassemia | 96,5 | 3,5 | ||||
| Minor β- thalassemia | 95,7 | 4,3 | ||||
| Minor β- thalassemia | 95,5 | 4,5 | ||||
| β- Thalassemia intermediar | 71 | 7,8 | 21,2 | |||
| Acquired elevation of HbF (anemic stress) | 93,4 | 2,4 | 4,2 | |||
| Acquired elevation of HbF (anemic stress) | 95,2 | 2,6 | 2,2 | |||
| Acquired elevation of HbF (diabetes) | 96,2 | 2,7 | 1,1 | |||
| Composite S/C sickle cell disease | 0,7 | 4,1 | 41,5 | 5,2 | 48,5 | |
| Composite S/C sickle cell disease | 1 | 2,7 | 39,3 | 13,6 | 43,4 | |
| Homozygous sickle cell disease (Transfusion context) | 48,2 | 3,4 | 3 | 45,4 | ||
| Homozygous sickle cell disease (Transfusion context) | 47,3 | 2,8 | 4 | 45,9 | ||
| Homozygous sickle cell disease (Transfusion context) | 0 | 3,1 | 14 | 82,9 | ||
| HbE variant (heterozygous) | 72,1 | 2,9 | 25 | |||
| HbC variant (heterozygous) | 61,2 | 3,8 | 35 | |||
| Delta chain variant (heterozygous) | 97,5 | 1,6 | 0,9 | |||
| Delta chain variant (heterozygous) | 97,7 | 2,3 | ||||
| Iron deficiency (5 subjects) | 97,6 (97,5;98,1) | 2,4 (1,9;2,5) | ||||
| Normal (9 subjects) | 97,4 (97;97,6) | 2,6 (2,4;2,7) |
The table 2 presents the results in hemoglobin electrophoresis in the first column and the respective percentage of hemoglobin A (HbA), hemoglobin A2 (HbA2), hemoglobin AN1 (HbAN1), hemoglobin C (HbC), hemoglobin F (HbF), and hemoglobin S (HbS). For the iron deficiency and normal patients, data are expressed as median, first and third quartile